AUG 21, 2020 1:42 PM PDT

Cancer Feels the STING

WRITTEN BY: Tara Fernandez

Researchers have discovered a protein that can amplify immune reactions against tumors. The stimulator of interferon genes, or STING for short, sends out signals to attract immune cells particularly during viral infections and the once cancerous cells are detected. STING has piqued the attention of oncology drug developers, particularly those who are hoping to harness its potent antitumor effects for new therapeutics.

Early work into creating STING-based treatments hit a roadblock due to the instability of STING activators — levels of these activators naturally taper off over time and do not last long in circulation.

A new study published in Science describes efforts by Scripps Research scientists who screened an array of small molecules with different structural conformations in search of those that activate STING. They discovered a single molecule which once optimized, was found to evoke a robust immune response in mouse models of metastatic melanoma, and curtailing the spread of the cancer.

Luke Lairson, co-senior author of the study said, “A systemic STING-activating molecule could have considerable utility, and not only as a therapeutic for cancer and infectious disease but also as a probe for studying STING-dependent antitumor immunity and a host of other STING-related biological processes.” 

The synthetic STING activator termed SR-717 mimics naturally occurring activators and has exciting potential as a future oncology drug. Once administered to mice with a particularly aggressive form of melanoma, SR-717 slowed tumor growth to a halt, blocked metastasis, and flagged immune cells such as CD8-positive and natural killer cells, mounting a full-blown cancer-killing response, all with no evidence of any unwanted side effects.

 


Sources: Science, Scripps Research.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 10, 2020
Immunology
Natural Killer Cells with "Memory" to Target Hepatitis B
JUN 10, 2020
Natural Killer Cells with "Memory" to Target Hepatitis B
An immune cell type thought to be restricted to the general, first response to pathogenic invaders may actually have som ...
JUL 17, 2020
Immunology
More Potential Antibody Therapies for COVID Emerge
JUL 17, 2020
More Potential Antibody Therapies for COVID Emerge
When it comes to clinical countermeasures against COVID-19, one class of molecules stands out among the others: antibodi ...
JUL 28, 2020
Immunology
Immune-Brain Connection in Rare Disease Puzzles Scientists
JUL 28, 2020
Immune-Brain Connection in Rare Disease Puzzles Scientists
Huntington’s disease (HD) is a rare, inherited, and incurable condition associated with the progressive degenerati ...
JUL 30, 2020
Genetics & Genomics
How Are DNA Testing Companies Helping the Fight Against COVID?
JUL 30, 2020
How Are DNA Testing Companies Helping the Fight Against COVID?
One of the most puzzling characteristics of coronavirus is how some people develop severe symptoms and die from the dise ...
AUG 10, 2020
Microbiology
The Tuberculosis Pathogen Is Captured Infecting a Cell
AUG 10, 2020
The Tuberculosis Pathogen Is Captured Infecting a Cell
Tuberculosis is caused by a bacterium, and it can infect immune cells called macrophages in the lungs that would normall ...
SEP 16, 2020
Immunology
Depression, but Not Anxiety, Causes Inflammation and Metabolic Imbalances
SEP 16, 2020
Depression, but Not Anxiety, Causes Inflammation and Metabolic Imbalances
Scientists have discovered that depressed individuals show higher levels of inflammation as well as elevated fat concent ...
Loading Comments...